Skip to main content
Please enter a legal issue and/or a location
Begin typing to search, use arrow keys to navigate, use enter to select

Find a Lawyer

More Options

Janssen Pharm. N.V. v. Teva Pharm. USA, Inc., No. 08-1594

By FindLaw Staff on September 25, 2009 | Last updated on March 21, 2019

In a patent case involving a method for treating Alzheimer's disease and related dementias, district court's conclusion that the claims of the patent '318 were invalid is affirmed as the patent's description of using galantamine to treat the disease does not satisfy the enablement requirement because the patent application did not establish utility.     

Read Janssen Pharm. N.V. v. Teva Pharm. USA, Inc., No. 08-1594

Appellate Information

Appeal from:  United States District Court for the District of New Jersey

Decided September 25, 2009


Before Mayer, Gajarsa, and Dyk, Circuit Judges

Opinion by Dyk, Circuit Judge.   


For Appellant:  George F. Pappas, Covington & Burling LLP

For Appellee:  William A. Rakoczy, Rakoczy Molino Mazzochi Siwik LLP; George C. Lombardi, Winston & Strawn LLP

You Don’t Have To Solve This on Your Own – Get a Lawyer’s Help

Meeting with a lawyer can help you understand your options and how to best protect your rights. Visit our attorney directory to find a lawyer near you who can help.

Or contact an attorney near you:
Copied to clipboard